Effects of Kaltenborn and Mulligan Mobilisation in Patients With Carpal Tunnel Syndrome.
Recruiting
N/A
Interventional Study
Carpal Tunnel Syndrome (CTS)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 20 – 45
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 48 (estimated)
- Sponsor
- Riphah International University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Carpal Tunnel Syndrome is the most common mononeuropathy that results from the compression of median nerve in carpal tunnel, leading to entrapment neuropathy. The symptoms become aggravated during drawing, typing or playing video games. The aim of study will be to compare the effects of Kaltenborn and Mulligan mobilisation on pain, disability and hand function in patients with carpal tunnel syndro…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Both genders between 20 and 45 years of age
* Individuals having localized pain, tingling and numbness in the median nerve distribution
* Positive Tinel sign and positive Phalen's test
Exclusion Criteria:
* Any sensory and/or motor deficit in either the ulnar or radial nerve…
Contacts